Insider Trading & Ownership - Dambkowski Carl

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Dambkowski Carl
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2025-04-02
Sale
2025-04-04
8:01 pm
Apogee Therapeutics Inc. APGE Dambkowski Carl
Chief Medical Officer
3,860 $36.22 $139,801 247,173
(Direct)
View
2025-03-05
Sale
2025-03-07
8:02 pm
Apogee Therapeutics Inc. APGE Dambkowski Carl
Chief Medical Officer
1,590 $30.48 $48,463 251,033
(Direct)
View
2025-02-05
Sale
2025-02-07
8:02 pm
Apogee Therapeutics Inc. APGE Dambkowski Carl
Chief Medical Officer
3,520 $40.69 $143,229 423,998
(Direct)
View
2025-01-02
Sale
2025-01-03
8:00 pm
Apogee Therapeutics Inc. APGE Dambkowski Carl
Chief Medical Officer
4,085 $46.94 $191,740 427,518
(Direct)
View
2024-12-11
Sale
2024-12-13
8:01 pm
Apogee Therapeutics Inc. APGE Dambkowski Carl
Chief Medical Officer
4,540 $48.76 $221,363 431,603
(Direct)
View
2024-12-04
Sale
2024-12-06
8:02 pm
Apogee Therapeutics Inc. APGE Dambkowski Carl
Chief Medical Officer
6,665 $46.07 $307,057 260,798
(Direct)
View
2024-11-06
Sale
2024-11-08
8:02 pm
Apogee Therapeutics Inc. APGE Dambkowski Carl
Chief Medical Officer
6,665 $59.12 $394,041 267,463
(Direct)
View
2024-10-02
Sale
2024-10-04
8:02 pm
Apogee Therapeutics Inc. APGE Dambkowski Carl
Chief Medical Officer
6,665 $56.26 $374,954 274,128
(Direct)
View
2024-09-04
Sale
2024-09-06
8:03 pm
Apogee Therapeutics Inc. APGE Dambkowski Carl
Chief Medical Officer
6,665 $47.56 $316,969 280,793
(Direct)
View
2024-08-07
Sale
2024-08-09
8:05 pm
Apogee Therapeutics Inc. APGE Dambkowski Carl
Chief Medical Officer
7,335 $40.67 $298,336 287,458
(Direct)
View
2024-07-03
Sale
2024-07-05
8:01 pm
Apogee Therapeutics Inc. APGE Dambkowski Carl
Chief Medical Officer
5,995 $37.6 $225,418 294,793
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-02-05
Exercise
2025-02-07
8:02 pm
N/A
N/A
Apogee Therapeutics Inc. APGE Dambkowski Carl
Chief Medical Officer
795 $22.86 423,998
(Direct)
View
2025-02-05
Exercise
2025-02-07
8:02 pm
N/A
2033-12-18
Apogee Therapeutics Inc. APGE Dambkowski Carl
Chief Medical Officer
795 $0 423,998
(Direct)
View
2025-01-02
Exercise
2025-01-03
8:00 pm
N/A
N/A
Apogee Therapeutics Inc. APGE Dambkowski Carl
Chief Medical Officer
1,360 $22.86 427,518
(Direct)
View
2025-01-02
Exercise
2025-01-03
8:00 pm
N/A
2033-12-18
Apogee Therapeutics Inc. APGE Dambkowski Carl
Chief Medical Officer
1,360 $0 427,518
(Direct)
View
2024-12-11
Exercise
2024-12-13
8:01 pm
N/A
N/A
Apogee Therapeutics Inc. APGE Dambkowski Carl
Chief Medical Officer
1,815 $22.86 431,603
(Direct)
View
2024-12-11
Exercise
2024-12-13
8:01 pm
N/A
2033-12-18
Apogee Therapeutics Inc. APGE Dambkowski Carl
Chief Medical Officer
1,815 $0 431,603
(Direct)
View
2024-12-09
Option Award
2024-12-11
8:01 pm
N/A
2034-12-09
Apogee Therapeutics Inc. APGE Dambkowski Carl
Chief Medical Officer
124,962 $0 124,962
(Direct)
View

Ownership
2024-09-06
5:05 pm
N/A
2024-05-06
Oruka Therapeutics Inc. ORKA Dambkowski Carl
Director
0 $0 94,282
(Direct)
View
2023-12-18
Option Award
2023-12-20
8:01 pm
N/A
2033-12-18
Apogee Therapeutics Inc. APGE Dambkowski Carl
Chief Medical Officer
175,345 $0 175,345
(Direct)
View

Ownership(A)
2023-07-17
5:06 pm
N/A
N/A
Apogee Therapeutics Inc. APGE Dambkowski Carl
Chief Medical Officer
0 $0 300,788
(Direct)
View

Ownership
2023-07-13
6:42 pm
N/A
N/A
Apogee Therapeutics Inc. APGE Dambkowski Carl
Chief Medical Officer
0 $0 279,105
(Direct)
View
(A) Indicate amendment filing.